Body Composition at Discharge and Neurological Development at 2 Years in Very Preterm Infants (OPTIPREMA)
NCT ID: NCT02686801
Last Updated: 2018-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2014-04-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Initial Nutritional Strategy and Stature-level Growth During the Neonatal Period of Children Born Moderately Premature
NCT03662503
Body Composition Reference Data for Preterm Infants
NCT02855814
Nutrition and Neurological Development of Very Preterm Infants
NCT02184650
Long Term Health Cohort of Premature Infants
NCT05017389
Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality
NCT06224764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OPTIPREMA aim to focus the link between nutrient intakes during hospitalization, body composition at discharge and relationship between fat free mass variations at discharge and neurodevelopment at 2 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted in the Neonatal unit before day-of-life 7, staying at least 15 days in the unit, and discharged home at ≥ 35 weeks postconceptional age directly from the neonatal unit (no transfer)
* Oral Parental consent
Exclusion Criteria
* Pathology inducing neurodevelopment troubles
* Transfer in an other hospital before discharge
* Hemodynamic or cardiovascular instability requiring continuous monitoring or perfusion, incompatible with pediatric air-displacement plethysmography
1 Week
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital de la Croix-Rousse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean-charles PICAUD, MD, PhD
Professor of pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean-charles picaud, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hopital de la croix rousse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital de la croix rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Larcade J, Pradat P, Buffin R, Leick-Courtois C, Jourdes E, Picaud JC. Estimation of Fat-free Mass at Discharge in Preterm Infants Fed With Optimized Feeding Regimen. J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):115-118. doi: 10.1097/MPG.0000000000001261.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPTIPREMA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.